Welcome, no impending Doom! Boom? Might be? Who knows but now the price is compressed and a trigger catalyst could turn the tide quickly. There are several on the immediate deck. I still believe Missling is a good strategist. (chess player?) The pieces are now in place. Impediments to a partnership or grant are all now removed. (SEC Investigation and Operational ATM for day to day expenses)One would assume that negotiations have been ongoing for a long time. Let us not forget the Allergan/Heptares Licensing deal. Parkinson's and ALZ news could be near term.
Today was just a bump in the road and could turn out to have been an ideal time to add.
Someone once said; "Buy when there is blood in the streets, (even if it is one's own!)" I would add; "Especially if it is one's own!"
Here we have a Company with NO DEBT, a favorable ATM financing plan where the Company can avoid future debt and very exciting drug with possibilities in a broad range of CNS disorders that has an extremely favorable safety profile.
The prime negative seems to be a well armed and determined short interest that is in dug into their short positions.
What do we need for this battle? 37,000 Barrels of Gasoline?
Anavex is on the beach and Anavex will not drown in debt or retreat so something must give.
It Might be a long battle or it could turn quickly, but it does seem to ME that ANAVEX LIFE SCIENCES will eventually press forward successfully.
Go AVXL!
JMHO
News 
Market Data 
Discover 
AI
